224 related articles for article (PubMed ID: 24006899)
1. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.
Kurokawa A; Nagata M; Kitamura N; Noman AA; Ohnishi M; Ohyama T; Kobayashi T; Shingaki S; Takagi R;
Cancer; 2008 Mar; 112(6):1272-81. PubMed ID: 18224668
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of cyclin-dependent kinase/cyclin-dependent kinase inhibitor expression ratios as biomarkers of locoregional and hematogenous dissemination risks in oral squamous cell carcinoma.
Nagata M; Kurita H; Uematsu K; Ogawa S; Takahashi K; Hoshina H; Takagi R
Mol Clin Oncol; 2015 Sep; 3(5):1007-1013. PubMed ID: 26623041
[TBL] [Abstract][Full Text] [Related]
4. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
Ma SR; Liu JF; Jia R; Deng WW; Jia J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive investigation regarding the clinical significance of ITGB4 in oral squamous cell carcinoma combining immunohistochemistry, RNA-seq, and microarray data.
Wang XM; Chen G; Dang YW; Li J; Li P; Li ZY
Comput Biol Chem; 2023 Jun; 104():107846. PubMed ID: 36934520
[TBL] [Abstract][Full Text] [Related]
7. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma.
Zhong F; Lu HP; Chen G; Dang YW; Li GS; Chen XY; Qin YY; Yao YX; Zhang XG; Liang Y; Li MX; Mo M; Zhang KL; Ding H; Huang ZG; Wei ZX
Pathol Res Pract; 2020 Feb; 216(2):152785. PubMed ID: 31889588
[TBL] [Abstract][Full Text] [Related]
9. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
10. CD9 and ITGA3 are regulated during HIV-1 infection in macrophages to support viral replication.
Kruize Z; Cobos Jiménez V; Martinez FO; Di Vincenzo R; van Dort KA; van Nuenen AC; Booiman T; Kootstra NA
Virology; 2021 Oct; 562():9-18. PubMed ID: 34242748
[TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
12. Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells.
Dmello C; Sawant S; Alam H; Gangadaran P; Tiwari R; Dongre H; Rana N; Barve S; Costea DE; Chaukar D; Kane S; Pant H; Vaidya M
Int J Biochem Cell Biol; 2016 Jan; 70():161-72. PubMed ID: 26646105
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
[TBL] [Abstract][Full Text] [Related]
14. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W
Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671
[TBL] [Abstract][Full Text] [Related]
15. Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers.
Miyamoto S; Maruyama A; Okugawa K; Akazawa K; Baba H; Maehara Y; Mekada E
Cancer; 2001 Aug; 92(3):542-8. PubMed ID: 11505398
[TBL] [Abstract][Full Text] [Related]
16. KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.
Shin WJ; Cho YA; Kang KR; Kim JH; Hong SD; Lee JI; Hong SP; Yoon HJ
APMIS; 2016 Apr; 124(4):291-8. PubMed ID: 26809635
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
19. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
